The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, T.
Right arrow Articles by Strober, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, T.
Right arrow Articles by Strober, S.
The Journal of Immunology, 2006, 176: 211-216.
Copyright © 2006 by The American Association of Immunologists

Expression of CD161 (NKR-P1A) Defines Subsets of Human CD4 and CD8 T Cells with Different Functional Activities1

Tsuyoshi Takahashi, Sussan Dejbakhsh-Jones and Samuel Strober2

Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305

A subset of T cells in human peripheral blood expresses CD161 (NKR-P1A) receptors that are primarily associated with NK cells. In the current study we isolated blood T cell subsets according to the expression of CD161 and examined their contents of naive, central memory, and effector memory cells and their capacities for proliferation, cytokine secretion, and natural cytolysis. We found that CD4+CD161 and CD8+CD161 subsets contained predominantly naive T cells that secreted high levels of IL-2 after in vitro stimulation, and CD4+CD161int and CD8+CD161int subsets contained predominantly effector and central memory T cells that secreted high levels of IFN-{gamma} and TNF-{alpha}. All of these subsets showed vigorous proliferation after stimulation in vitro, but none had NK lytic activity. Unexpectedly, the CD8+CD161+ cells contained an anergic CD8{alpha}+CD8{beta}low/–CD161high T cell subset that failed to proliferate, secrete cytokines, or mediate NK lytic activity.




This article has been cited by other articles:


Home page
BloodHome page
E. Huarte, J. R. Cubillos-Ruiz, Y. C. Nesbeth, U. K. Scarlett, D. G. Martinez, X. A. Engle, W. F. Rigby, P. A. Pioli, P. M. Guyre, and J. R. Conejo-Garcia
PILAR is a novel modulator of human T-cell expansion
Blood, August 15, 2008; 112(4): 1259 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Cosmi, R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al.
Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor
J. Exp. Med., August 4, 2008; 205(8): 1903 - 1916.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. Rosen, W. Cao, D. T. Avery, S. G. Tangye, Y.-J. Liu, J. P. Houchins, and L. L. Lanier
Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells
J. Immunol., May 15, 2008; 180(10): 6508 - 6517.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. D. Scandling, S. Busque, S. Dejbakhsh-Jones, C. Benike, M. T. Millan, J. A. Shizuru, R. T. Hoppe, R. Lowsky, E. G. Engleman, and S. Strober
Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation
N. Engl. J. Med., January 24, 2008; 358(4): 362 - 368.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Roth, M. Mittelbronn, W. Wick, R. Meyermann, M. Tatagiba, and M. Weller
Malignant Glioma Cells Counteract Antitumor Immune Responses through Expression of Lectin-Like Transcript-1
Cancer Res., April 15, 2007; 67(8): 3540 - 3544.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. G. Iliopoulou, M. V. Karamouzis, I. Missitzis, A. Ardavanis, N. N. Sotiriadou, C. N. Baxevanis, G. Rigatos, M. Papamichail, and S. A. Perez
Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients
Clin. Cancer Res., December 1, 2006; 12(23): 6901 - 6909.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.